The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating immune protein biomarkers of early response and resistance in patients with metastatic HER-2–negative esophagogastric cancer (mEGC) treated with pembrolizumab and chemotherapy.
 
Andrew B. Nixon
Consulting or Advisory Role - Leap Therapeutics; Sanofi
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Genmab (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Patent (Inst); Patent Pending (Inst)
 
Lauren Howard
No Relationships to Disclose
 
Amrita Kar
No Relationships to Disclose
 
Yingmiao Liu
No Relationships to Disclose
 
John C. Brady
No Relationships to Disclose
 
Donna Niedzwiecki
No Relationships to Disclose
 
John H Strickler
Stock and Other Ownership Interests - Triumvira Immunologics, Inc
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Beigene; Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Merck; Natera (Inst); Pfizer; Roche/Genentech; Seagen; Taiho Oncology; Takeda
Research Funding - A*STAR (Inst); Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Curegenix (Inst); Daiichi Sankyo/Lilly (Inst); Erasca, Inc (Inst); GlaxoSmithKline (Inst); Leap Therapeutics (Inst); Lilly (Inst); Roche/Genentech (Inst); Seagen (Inst)
Expert Testimony - Seagen
Travel, Accommodations, Expenses - Seagen
 
Marijana Rucevic
No Relationships to Disclose
 
Hope Elizabeth Uronis
Employment - GeneCentric (I)
Stock and Other Ownership Interests - GeneCentric (I)
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex
Research Funding - Adaptimmune (Inst); Arcus Biosciences (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Leap Therapeutics (Inst); Macrogenics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb